Short-Chain Fatty Acids Augment Differentiation and Function of Human Induced Regulatory T Cells.
Level 5 - mechanism / opinion, no new human data
In vitro bench study using human primary cell samples
PubMed 35628549 · doi:10.3390/ijms23105740
What was done
Naïve CD4+ non-Treg cells were isolated from the peripheral blood of 13 healthy adults and umbilical cord blood of 12 healthy term newborns. Cells were differentiated toward induced regulatory T cells (iTregs) using a transforming growth factor beta (TGF-β)-based protocol with or without short-chain fatty acids (acetate, butyrate, or propionate). Cells were analyzed via flow cytometric phenotyping, functional suppression assays, and chromatin-immunoprecipitation (ChIP) to assess histone acetylation levels during differentiation.
What was found
Adding butyrate or propionate to the TGF-β protocol increased the in vitro differentiation of human naïve CD4+ non-Tregs into iTregs and enhanced their suppressive function. These effects were accompanied by alterations in histone acetylation levels during differentiation. GITR, ICOS, CD39, PD-1, and PD-L1 were identified as phenotypic markers of the generated human iTregs. The abstract does not report numerical values, percentages, or statistical effect sizes.
Why it matters
This study demonstrates an approach to generate functionally suppressive human iTregs in vitro using microbial metabolites, providing mechanistic insight and potential markers for developing cell therapies against autoimmune and inflammatory diseases.
Limits
The study is restricted to in vitro bench assays and does not test in vivo persistence, migration, or therapeutic efficacy. The donor sample was small (25 total donors: 13 adults, 12 newborns), and no numerical data or effect sizes are provided in the abstract.
Cited by
- supports Short-chain fatty acids produced by gut bacteria fermentation, including acetate, butyrate, and propionate, increase the number of regulatory T cells to modulate autoimmune responses.